213 related articles for article (PubMed ID: 19812208)
1. Resistance of human alveolar macrophages to Bacillus anthracis lethal toxin.
Wu W; Mehta H; Chakrabarty K; Booth JL; Duggan ES; Patel KB; Ballard JD; Coggeshall KM; Metcalf JP
J Immunol; 2009 Nov; 183(9):5799-806. PubMed ID: 19812208
[TBL] [Abstract][Full Text] [Related]
2. Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival.
Ribot WJ; Panchal RG; Brittingham KC; Ruthel G; Kenny TA; Lane D; Curry B; Hoover TA; Friedlander AM; Bavari S
Infect Immun; 2006 Sep; 74(9):5029-34. PubMed ID: 16926394
[TBL] [Abstract][Full Text] [Related]
3. Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity.
Moayeri M; Martinez NW; Wiggins J; Young HA; Leppla SH
Infect Immun; 2004 Aug; 72(8):4439-47. PubMed ID: 15271901
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b.
Terra JK; Cote CK; France B; Jenkins AL; Bozue JA; Welkos SL; LeVine SM; Bradley KA
J Immunol; 2010 Jan; 184(1):17-20. PubMed ID: 19949100
[TBL] [Abstract][Full Text] [Related]
5. Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.
Loving CL; Khurana T; Osorio M; Lee GM; Kelly VK; Stibitz S; Merkel TJ
Infect Immun; 2009 Jan; 77(1):255-65. PubMed ID: 18955474
[TBL] [Abstract][Full Text] [Related]
6. Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains.
Drysdale M; Olson G; Koehler TM; Lipscomb MF; Lyons CR
Infect Immun; 2007 Apr; 75(4):1757-64. PubMed ID: 17242059
[TBL] [Abstract][Full Text] [Related]
7. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
Scobie HM; Wigelsworth DJ; Marlett JM; Thomas D; Rainey GJ; Lacy DB; Manchester M; Collier RJ; Young JA
PLoS Pathog; 2006 Oct; 2(10):e111. PubMed ID: 17054395
[TBL] [Abstract][Full Text] [Related]
8. Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages.
Raymond B; Leduc D; Ravaux L; Le Goffic R; Candela T; Raymondjean M; Goossens PL; Touqui L
PLoS Pathog; 2007 Dec; 3(12):e187. PubMed ID: 18069891
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional and apoptotic responses of THP-1 cells to challenge with toxigenic, and non-toxigenic Bacillus anthracis.
Bradburne C; Chung MC; Zong Q; Schlauch K; Liu D; Popova T; Popova A; Bailey C; Soppet D; Popov S
BMC Immunol; 2008 Nov; 9():67. PubMed ID: 19014542
[TBL] [Abstract][Full Text] [Related]
10. Resident CD11c+ lung cells are impaired by anthrax toxins after spore infection.
Cleret A; Quesnel-Hellmann A; Mathieu J; Vidal D; Tournier JN
J Infect Dis; 2006 Jul; 194(1):86-94. PubMed ID: 16741886
[TBL] [Abstract][Full Text] [Related]
11. Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection.
Cote CK; DiMezzo TL; Banks DJ; France B; Bradley KA; Welkos SL
Microbes Infect; 2008 May; 10(6):613-9. PubMed ID: 18467145
[TBL] [Abstract][Full Text] [Related]
12. Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production.
Fang H; Xu L; Chen TY; Cyr JM; Frucht DM
J Immunol; 2006 May; 176(10):6155-61. PubMed ID: 16670324
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo.
Little SF; Webster WM; Fisher DE
FEMS Immunol Med Microbiol; 2011 Jun; 62(1):11-22. PubMed ID: 21231965
[TBL] [Abstract][Full Text] [Related]
14. Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge.
Banks DJ; Barnajian M; Maldonado-Arocho FJ; Sanchez AM; Bradley KA
Cell Microbiol; 2005 Aug; 7(8):1173-85. PubMed ID: 16008584
[TBL] [Abstract][Full Text] [Related]
15. Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity.
Fukao T
Lancet Infect Dis; 2004 Mar; 4(3):166-70. PubMed ID: 14998502
[TBL] [Abstract][Full Text] [Related]
16. The alveolar macrophage: the Trojan horse of Bacillus anthracis.
Guidi-Rontani C
Trends Microbiol; 2002 Sep; 10(9):405-9. PubMed ID: 12217505
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore.
Xu Q; Hesek ED; Zeng M
Microb Pathog; 2007 Jul; 43(1):37-45. PubMed ID: 17459655
[TBL] [Abstract][Full Text] [Related]
18. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity.
Crawford MA; Aylott CV; Bourdeau RW; Bokoch GM
J Immunol; 2006 Jun; 176(12):7557-65. PubMed ID: 16751402
[TBL] [Abstract][Full Text] [Related]
19. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.
Liu S; Miller-Randolph S; Crown D; Moayeri M; Sastalla I; Okugawa S; Leppla SH
Cell Host Microbe; 2010 Nov; 8(5):455-62. PubMed ID: 21075356
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathogenesis of Bacillus anthracis infection.
Little SF; Ivins BE
Microbes Infect; 1999 Feb; 1(2):131-9. PubMed ID: 10594977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
